Lohocla Research Corporation
USPTO PatentsView assignee record - 5 granted patents across 3 technology areas, recorded in grant years 2018–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).
The verdict
According to USPTO PatentsView, Lohocla ranks #48,439 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 3 technology areas.
- #48,439
- of 49,997 US assignees by volume
- 21st percentile
- by Innovation Score (26.6/100)
- 23.8
- avg claims per patent
- -33%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R48439 · US Corporation #48,439 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DOWN · BOOK-FULL
- GRANTS-MICRO 5 grants
- BOTTOM-DECILE #48,439/49,997
- PHOTO-FINISH Loc-aid
- CPC-NARROW C07D · 3 areas
- INNOV-THIN 26.6/100
- CLAIMS-DENSE 23.8 claims/avg
- TYPE-USCORP US Corporation
- VEL-DOWN -33% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Loc-aid Technologies, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Lohocla’s 26.6 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Lohocla
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Lohocla Research · this assignee 27
Lohocla Research · this assignee
27 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Lohocla's Innovation Score is 26.6/100 (21st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Lohocla?
Each dot is one of Lohocla’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Lohocla’s own 23.8 claims/patent is ABOVE the 16.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Lohocla's grants concentrate
Lohocla Research Corporation is a focused PatentsView assignee: 3 CPC subclasses with 80% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2019 (2 grants) versus a trough of 1 in 2018. By volume, Lohocla sits between Loc-aid Technologies, Inc. and Longwide Technology Inc..
Who files at Lohocla's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Loc-aid
Loc-aid Technologies, Inc.
5 patents
- Loeb Enterprises
Loeb Enterprises, Inc
5 patents
- Logicink
Logicink Corporation
5 patents
- Logisteed
Logisteed, Ltd.
5 patents
- Lomanco
Lomanco, Inc.
5 patents
- Long Pipes USA
Long Pipes USA, Inc.
5 patents
- Longvale
Longvale Ltd
5 patents
- Longwide Technolo…
Longwide Technology Inc.
5 patents
- Lohocla Research ◀
Lohocla Research Corporation
5 patents
What this shows Lohocla holds 5 patents at rank #48,353, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Lohocla
By rank, the assignees closest to #48,353 in granted patent volume.
- Loc-aid Technologies, Inc. #48,349 · 5 patents
- Loeb Enterprises, Inc #48,350 · 5 patents
- Logicink Corporation #48,351 · 5 patents
- Logisteed, Ltd. #48,352 · 5 patents
- Lomanco, Inc. #48,354 · 5 patents
- Long Pipes USA, Inc. #48,355 · 5 patents
- Longvale Ltd #48,356 · 5 patents
- Longwide Technology Inc. #48,357 · 5 patents
Leaders in C07D (Heterocyclic Compounds)
Other assignees with the most granted patents in Lohocla's primary technology class.
Lohocla's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
27 21st percentile higher than 21% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 20.0% |
| 2019 | 2 | 40.0% |
| 2020 | 1 | 20.0% |
| 2021 | 1 | 20.0% |
Which technologies does Lohocla Research Corporation patent most?
Top 3 of 3 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Lohocla Research Corporation's patent record in context - here's where to go next.
- Lohocla Research Corporation's lead technology class is C07D (Heterocyclic Compounds), 80% of its portfolio - see every assignee active in that class. Explore C07D
- Ranked #48,439 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Lohocla Research Corporation against Loc-aid Technologies, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 26.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.